Showing results (61-70 of 96) with videos related to
Sort By:
Pageof 10
Investigational New Drugs|January 29, 2013
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortiumSrikala S Sridhar, Mary J Mackenzie, Sebastien J Hotte, et al.The New England Journal of Medicine|July 18, 2003
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancerChristine M Ribic, Daniel J Sargent, Malcolm J Moore, et al.American Journal of Clinical Oncology|January 1, 2010
A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancerSrikala S Sridhar, Sebastien J Hotte, Joseph L Chin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2009
A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortiumNatasha B Leighl, Scott A Laurie, Xueyu E Chen, et al.British Journal of Cancer|July 13, 2016
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)Dewi Vernerey, Florence Huguet, Angélique Vienot, et al.European Urology|December 31, 2010
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experienceJeremy F Sturgeon, Malcolm J Moore, David M Kakiashvili, et al.Investigational New Drugs|June 11, 2003
Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeksAlison J Davis, Karen A Gelmon, Lillian L Siu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J Moore, David Goldstein, John Hamm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapyAmirrtha Srikanthan, Ben Tran, Michel Beausoleil, et al.Pageof 10